[Oncornavirus, biological and immunological considerations].
D000818:Animals; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D002471:Cell Transformation, Neoplastic; D004279:DNA, Viral / Q000378:metabolism; D000939:Epitopes; D006023:Glycoproteins / Q000032:analysis; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000209:etiology; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation; D007938:Leukemia / Q000382:microbiology; D051379:Mice; D008854:Microscopy, Electron; D009858:Oncogenic Viruses / Q000032:analysis / Q000145:classification / Q000276:immunology*; D010641:Phenotype; D012367:RNA, Viral / Q000378:metabolism; D012509:Sarcoma / Q000382:microbiology; D014184:Transplantation, Homologous; D014764:Viral Proteins / Q000032:analysis; D014779:Virus Replication
D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D004279:DNA, Viral; D000939:Epitopes; D006023:Glycoproteins; D007166:Immunosuppressive Agents; D012367:RNA, Viral; D014764:Viral Proteins
Oncornavirus considerazioni biologiche e immunologiche.